Sponsored diagnostic testing programs for Inherited Retinal Disease (IRD)
Inherited retinal diseases (IRDs) are a group of genetic disorders that cause progressive dysfunction of the retina, leading to vision loss that can range from mild impairment to blindness. IRDs can affect photoreceptor cells, the retinal pigment epithelium, or other retinal structures, and may present in childhood or adulthood. Genetic testing helps clarify the underlying cause, guide prognosis, and identify individuals who may be eligible for emerging therapies.
2 programs found for Inherited Retinal Disease (IRD)
This program offers U.S. clinicians access to comprehensive genetic testing for patients with suspected inherited retinal diseases, including RP, CRD, LCA, Stargardt disease, and other IRDs. Testing is also appropriate for asymptomatic individuals with a family history of IRD or a known pathogenic variant in a relevant gene, supporting diagnosis, risk assessment, and patient management.
This program offers no-cost 110-gene panel testing for patients with a clinically confirmed inherited retinal disease (IRD). Testing supports molecular diagnosis, guides management decisions, and helps identify individuals who may qualify for targeted therapies or clinical research. Eligible patients must enroll through the Program workflow and complete all required consent and HIPAA documentation.
